within Pharmacolibrary.Drugs.ATC.J;

model J01DD07
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0114,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.007940000000000001,
    k12             = 17.7,
    k21             = 17.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DD07</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ceftizoxime is a third-generation cephalosporin antibiotic indicated for the treatment of a variety of bacterial infections including respiratory tract, urinary tract, skin and soft tissue infections. It was previously widely used but has been largely replaced by newer agents and is not commonly used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single intravenous injection.</p><h4>References</h4><ol><li><p>Cutler, RE, et al., &amp; Parks, D (1982). Pharmacokinetics of ceftizoxime. <i>The Journal of antimicrobial chemotherapy</i> 10 Suppl C 91–97. DOI:<a href=&quot;https://doi.org/10.1093/jac/10.suppl_c.91&quot;>10.1093/jac/10.suppl_c.91</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6296034/&quot;>https://pubmed.ncbi.nlm.nih.gov/6296034</a></p></li><li><p>Gundert-Remy, U, et al., &amp; Schlegel, P (1985). Pharmacokinetics of ceftizoxime. <i>European journal of clinical pharmacology</i> 28(4) 463–467. DOI:<a href=&quot;https://doi.org/10.1007/BF00544368&quot;>10.1007/BF00544368</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3861322/&quot;>https://pubmed.ncbi.nlm.nih.gov/3861322</a></p></li><li><p>LeBel, M, et al., &amp; Lewis, GP (1983). Effect of probenecid on the pharmacokinetics of ceftizoxime. <i>The Journal of antimicrobial chemotherapy</i> 12(2) 147–155. DOI:<a href=&quot;https://doi.org/10.1093/jac/12.2.147&quot;>10.1093/jac/12.2.147</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6311785/&quot;>https://pubmed.ncbi.nlm.nih.gov/6311785</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DD07;
